TABLE 3.
Panel A | |||
---|---|---|---|
Interacting residues | Bond type | Bond distance (Å) | |
LL‐37 (PDB ID: 2K6O) | SARS‐CoV‐2 RBD (PDB ID: 6LZG) (−253.75) a | ||
Asn30 | Asn501 | HB | 1.67 |
Phe27 | Gly496 | Ar‐HB | 2.75 |
Asp26 | Tyr505 | Ar‐HB | 2.73 |
Arg23 | Tyr505 | HB | 2.48 |
Arg23 | Glu406 | Salt Bridge | 4.12 |
Glu16 | Lys417 | Salt Bridge | 3.18 |
Glu16 | Lys417 | HB | 2.53 |
Glu16 | Tyr421 | Ar‐HB | 1.75 |
LL‐37 (PDB ID: 2K6O) | SARS‐CoV‐2 RBD (PDB ID: 6M0J) (−238.18) a | ||
---|---|---|---|
Asp26 | Tyr505 | Ar‐HB | 2.96 |
Phe27 | Gly496 | Ar‐HB | 2.82 |
Arg23 | Tyr505 | HB | 2.74 |
Arg23 | Glu406 | Salt Bridge | 3.25 |
Glu16 | Phe456 | Ar‐HB | 3.38 |
Glu16 | Lys417 | Salt Bridge | 3.09 |
Glu16 | Tyr421 | Ar‐HB | 2.25 |
Glu16 | Tyr421 | HB | 1.94 |
Panel B | |||
---|---|---|---|
Interacting residues | Bond type | Bond distance (Å) | |
PACAP‐38 (PDB ID: 2D2P) | SARS‐CoV‐2 RBD (PDB ID: 6LZG) (−230.30) a | ||
Lys15 | Leu455 | HB | 1.56 |
Arg12 | Phe456 | Ar‐HB | 2.63 |
Tyr13 | Tyr489 | Pi‐Pi | 5.46 |
Arg30 | Gln498 | 2 HB | 1.71, 2.08 |
Amylin (PDB ID: 2KB8) | SARS‐CoV‐2 RBD (PDB ID: 6LZG) (−229.10) a | ||
---|---|---|---|
Phe23 | Gly446 | Ar‐HB | 2.63 |
Phe23 | Tyr449 | Ar‐HB | 3.55 |
Ser19 | Tyr449 | HB | 1.90 |
Asn14 | Tyr505 | Ar‐HB | 2.37 |
Asn14 | Arg403 | HB | 2.09 |
Lys1 | Asp420 | Salt Bridge | 4.27 |
Lys1 | Asn460 | HB | 1.15 |
GLP‐2 (PDB ID: 2L63) | SARS‐CoV‐2 RBD (PDB ID: 6LZG) (−202.59) a | ||
---|---|---|---|
Phe22 | Asn450 | Ar‐HB | 2.85 |
His1 | Asn343 | HB | 2.23 |
His1 | Glu340 | Ar‐HB | 3.28 |
LL‐37 (PDB ID: 2K6O) (PDB ID: 2K6O) | SARS‐CoV‐2 region adjacent to RBD (PDB ID: 6LZG) (−209.74) a | ||
---|---|---|---|
Phe17 | Phe238 | Pi‐Pi | 4.80 |
Arg7 | Asp138 | Salt Bridge | 3.13 |
Abbreviations: Ar‐HB, aromatic hydrogen bond; HB, hydrogen bond; Pi‐Pi, non‐covalent interaction between aromatic rings.
Docking score.